Viveash Dawn 4
4 · Orexigen Therapeutics, Inc. · Filed Sep 22, 2010
Insider Transaction Report
Form 4
Viveash Dawn
Head of Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2010-09-20+45,000→ 45,000 totalExercise: $5.89Exp: 2020-09-19→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant beginning the earlier of (i) February 28, 2011 or (ii) one month following the meeting of the Compensation Committee of the Company's Board of Directors in January 2011, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]Not applicable.